Nicholas Lydon Insider Trading $ANAB ANAPTYSBIO, INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Nicholas Lydon.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Nicholas Lydon. Nicholas Lydon is Director in ANAPTYSBIO INC ($ANAB) and Director in Blueprint Medicines Corp ($BPMC).
Nicholas Lydon in ANAPTYSBIO, INC
Trading Symbol: ANABIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Nicholas Lydon: Director
Holdings: 301,506 shares
Current Value: $5,589,921
Latest Transaction: Feb 11 2019
$ANAB Market Capitalization: $365.89M
$ANAB Previous Close: $18.54
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Nicholas Lydon in ANAPTYSBIO, INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 11 2019 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Option Exercise | A | 68.89 | 6,000 | 413,340 | 6,000 | |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 90.26 | 2,222 | 200,549 | 271,106 | 273.3 K to 271.1 K (-0.81 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 89.42 | 2,803 | 250,631 | 273,328 | 276.1 K to 273.3 K (-1.02 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 88.30 | 4,250 | 375,267 | 276,131 | 280.4 K to 276.1 K (-1.52 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 87.46 | 9,425 | 824,341 | 280,381 | 289.8 K to 280.4 K (-3.25 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 86.15 | 1,390 | 119,753 | 289,806 | 291.2 K to 289.8 K (-0.48 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 85.11 | 10,310 | 877,491 | 291,196 | 301.5 K to 291.2 K (-3.42 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 84.18 | 2,600 | 218,880 | 301,506 | 304.1 K to 301.5 K (-0.85 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 90.26 | 2,222 | 200,549 | 271,106 | 273.3 K to 271.1 K (-0.81 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 89.42 | 2,803 | 250,631 | 273,328 | 276.1 K to 273.3 K (-1.02 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 88.30 | 4,250 | 375,267 | 276,131 | 280.4 K to 276.1 K (-1.52 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 87.46 | 9,425 | 824,341 | 280,381 | 289.8 K to 280.4 K (-3.25 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 86.15 | 1,390 | 119,753 | 289,806 | 291.2 K to 289.8 K (-0.48 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 85.11 | 10,310 | 877,491 | 291,196 | 301.5 K to 291.2 K (-3.42 %) |
Apr 18 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Sell | S | 84.18 | 2,600 | 218,880 | 301,506 | 304.1 K to 301.5 K (-0.85 %) |
Feb 20 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Option Exercise | M | 4.55 | 16,483 | 74,998 | 0 | |
Feb 20 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Buy | M | 4.55 | 16,483 | 74,998 | 304,106 | 287.6 K to 304.1 K (+5.73 %) |
Feb 06 2018 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Option Exercise | A | 104.81 | 6,000 | 628,860 | 6,000 | |
Feb 28 2017 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Option Exercise | A | 24.60 | 15,000 | 369,000 | 15,000 | |
Jan 31 2017 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Option Exercise | C | 0.00 | 67,345 | 0 | 0 | |
Jan 31 2017 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Option Exercise | C | 0.00 | 55,403 | 0 | 0 | |
Jan 31 2017 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Option Exercise | C | 0.00 | 80,877 | 0 | 0 | |
Jan 31 2017 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Buy | P | 15.00 | 16,666 | 249,990 | 287,623 | 271 K to 287.6 K (+6.15 %) |
Jan 31 2017 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Buy | C | 0.00 | 203,625 | 0 | 270,957 | 67.3 K to 271 K (+302.42 %) |
Page: 1